|
|
c/o LIMR, Room 222
Wynnewood, PA 19096 USA
phone:484-476-1396
fax:484-771-0009
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
2006 |
| Employees |
4 |
|
|
| www.immunomeinc.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Provides unbiased immune response method to combat infectious disease, neurological, cancer, and autoimmune diseases. |
|
| Management |
| Timothy Pelura, CEO; Scott Dessain, Chief Scientific Officer; George Hobbs, SVP Corporate Development and General Counsel |
| |
|
|
| |
|
| Keywords |
| infectious disease, immune, cancer, biodefense, neurological, vaccine |
|
|
|
| Description |
|
Immunome is a discovery stage biopharmaceutical company that has created a
proprietary Native Human Monoclonal Antibody (N-huMAB) platform. N-huMAbs are in the exact structures created by nature and possess the natural safety and protective power of the human immune system. The strength of the Immunome technology is its ability to capture the innate curative immune response to infectious diseases and vaccines. Because the Immunome method is intrinsically unbiased, Immunome is able to obtain N-huMAbs not accessible by other antibody cloning methods. Immunome has captured high affinity, potent N-huMAbs in several therapeutic classes - cancer, infectious disease, neurological illness, and bio-defense.
Funding internal programs on nondilutive partnership capital. Currently has one collaboration with large pharma and is negotiating a second outlicense deal. |
|
| Products / Services |
Native human antibodies for therapy and diagnosis.
|
|
| Technology / Differentiation |
| Human hybridoma platform for native human antibody isolation. |
|
|
| Strategy |
Clinical development through POC studies and multiple partnerships/collaborations on proprietary targets to generate non-dilutive capital.
|
|
| Funding |
| $1.9M in angel and grants to date.
Currently raising $650K remainder of seed financing. Partnership dollars are supporting internal cancer program. |
|
| Status |
| Preclinical stage. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members